Catridecacog - Dosage, Indication, Contraindication, and Administration
Catridecacog is a recombinant FXIII, A subunit molecule being studied for clotting factor replacement therapy in patients with congenital FXIII deficiency.
Dr. Kaushal Bhavsar
